Telehealth for menopause in Texas: HRT evaluation, symptom management, and what labs to check

What is menopause and can a telehealth provider help?

Menopause is defined as 12 consecutive months without a menstrual period, occurring at a median age of 51.4 years in the U.S. (SWAN: Study of Women's Health Across the Nation). The perimenopause transition — which precedes the final period by 4–8 years — often produces the most disruptive symptoms: irregular cycles, vasomotor episodes (hot flashes, night sweats), sleep disruption, mood changes, brain fog, and genitourinary symptoms (dryness, urgency, recurrent UTIs). A Texas-licensed Copergrine Health & Wellness provider can evaluate your symptom pattern, order appropriate labs, discuss evidence-based treatment including hormone replacement therapy (HRT), and manage your care through the transition — same-day telehealth available.

The Menopause Society (formerly NAMS) 2023 Position Statement on Hormone Therapy confirms that for healthy women under 60, or within 10 years of menopause onset, the benefits of HRT for symptomatic relief outweigh the risks for most patients without contraindications.

What labs does a provider order before starting HRT?

Before initiating hormone therapy, a Copergrine provider reviews or orders:

• FSH and estradiol — confirm menopausal status (FSH ≥ 40 mIU/mL combined with low estradiol confirms menopause in the appropriate clinical context)
• TSH — thyroid dysfunction shares overlapping symptoms with perimenopause (fatigue, mood changes, irregular periods); exclude before attributing findings to hormones
• CBC — baseline complete blood count
• Lipid panel and fasting glucose — cardiovascular baseline; important for the safety discussion around HRT in individual patients
• Mammogram — current within the last 12 months (standard screening; your provider will ask for your most recent date)
• Pap smear status — current on cervical screening

Labs are ordered electronically and drawn at a local draw site; results are available in your Copergrine chart within 24–48 hours for a results-review follow-up.

What HRT options can a Texas telehealth provider prescribe?

Systemic estrogen (first-line for moderate-to-severe vasomotor symptoms):

• Transdermal estradiol patch (generic, various strengths) — NAMS 2023 preferred over oral due to lower venous thromboembolism (VTE) risk from avoided first-pass hepatic metabolism
• Estradiol gel (Divigel, EstroGel) or spray (Evamist)
• Oral estradiol tablets (Estrace) — effective but carries slightly higher VTE risk profile vs. transdermal

Progestogen (required for patients with an intact uterus to protect the endometrium):

• Micronized progesterone (Prometrium) — NAMS 2023 preferred; natural progesterone is associated with a lower breast cancer risk signal and better sleep than synthetic progestins
• Medroxyprogesterone acetate (synthetic progestin, combined formulations)

Vaginal estrogen (local therapy for genitourinary syndrome of menopause, GSM): Vaginal estradiol cream, tablet (Vagifem/Yuvafem), or ring (Estring). Minimal systemic absorption; can be used longer-term without mandatory progestogen addition in most patients. Effective for dryness, dyspareunia, urgency, and recurrent UTIs attributable to GSM.

Non-hormonal prescription options for vasomotor symptoms:

• Fezolinetant (Veozah) — FDA-approved 2023; NK3 receptor antagonist, 45 mg daily, not a hormone; meaningful reduction in hot flash frequency and severity at 4 weeks
• Low-dose paroxetine (Brisdelle 7.5 mg) — the only non-hormonal FDA-approved agent for vasomotor symptoms
• Venlafaxine or gabapentin — off-label but widely used with published evidence for vasomotor symptom reduction

When does menopause care require in-person evaluation?

In-person evaluation is warranted when:

• Unexpected or heavy vaginal bleeding requires pelvic exam and possible endometrial biopsy before starting systemic estrogen
• A personal history of hormone-receptor-positive breast cancer, active VTE, liver disease, or uncontrolled cardiovascular disease requires specialist coordination before any hormone decision
• Pelvic floor symptoms (prolapse, urinary incontinence) require in-person pelvic examination
• A physical exam or procedure (e.g., placement of a hormonal IUD for progestogen coverage) cannot be performed remotely

A Copergrine provider coordinates in-person referral where needed and continues telehealth follow-up for ongoing management.

FAQ: Telehealth for menopause in Texas

Can a telehealth provider in Texas prescribe estrogen and progesterone?

Yes. Texas-licensed providers can prescribe FDA-approved systemic and local hormone therapy via telehealth for eligible patients. The evaluation covers symptom pattern, recent labs, personal and family medical history, screening status, and contraindications before prescribing. A telehealth visit alone cannot substitute for a pelvic exam or biopsy when one is clinically indicated (e.g., unexplained vaginal bleeding before starting systemic estrogen).

How long does it take for HRT to work?

Vasomotor symptoms — hot flashes and night sweats — typically improve within 4–8 weeks of reaching a therapeutic transdermal estradiol level. Genitourinary symptoms respond more slowly; consistent vaginal estrogen for 8–12 weeks is usually needed before meaningful improvement. Mood and sleep often improve within 2–4 weeks. A follow-up visit at 8–12 weeks allows your Copergrine provider to assess response, confirm lab safety parameters, and adjust dose or delivery route.

Is HRT still safe in 2026?

The 2023 Menopause Society Position Statement confirms that for most healthy, symptomatic women under 60 who are within 10 years of their final menstrual period, the benefit of HRT for quality-of-life outcomes exceeds the risk for those without contraindications. The 2002 WHI study that alarmed the field involved older, post-menopausal women on oral conjugated estrogens plus synthetic progestin — a population and regimen distinct from transdermal estradiol plus micronized progesterone started in early menopause. Your Copergrine provider reviews your individual history and risk profile before any recommendation.

---

Menopause care should be evidence-based and personalized. A Copergrine Health & Wellness provider evaluates your labs, symptoms, and history to determine what's right for you — same-day telehealth available. Book a visit at health.copergrine.com/services/hormone-therapy